<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns:mv="http://macVmlSchemaUri" xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta name=Title content="">
<meta name=Keywords content="">
<meta http-equiv=Content-Type content="text/html; charset=macintosh">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 14">
<meta name=Originator content="Microsoft Word 14">
<link rel=File-List href="PLOS-One%20Response_files/filelist.xml">
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Dave Bridges</o:Author>
  <o:LastAuthor>Dave Bridges</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>4</o:TotalTime>
  <o:Created>2014-10-19T23:35:00Z</o:Created>
  <o:LastSaved>2014-10-19T23:35:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>7063</o:Words>
  <o:Characters>40262</o:Characters>
  <o:Company>UT-HSC</o:Company>
  <o:Lines>335</o:Lines>
  <o:Paragraphs>94</o:Paragraphs>
  <o:CharactersWithSpaces>47231</o:CharactersWithSpaces>
  <o:Version>14.0</o:Version>
 </o:DocumentProperties>
 <o:CustomDocumentProperties>
  <o:Mendeley_x0020_Document_1 dt:dt="string">True</o:Mendeley_x0020_Document_1>
  <o:Mendeley_x0020_User_x0020_Name_1 dt:dt="string">davebrid@lsi.umich.edu@www.mendeley.com</o:Mendeley_x0020_User_x0020_Name_1>
  <o:Mendeley_x0020_Citation_x0020_Style_1 dt:dt="string">http://www.zotero.org/styles/plos-one</o:Mendeley_x0020_Citation_x0020_Style_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_0_1 dt:dt="string">http://www.zotero.org/styles/american-political-science-association</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_0_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_0_1 dt:dt="string">American Political Science Association</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_0_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_1_1 dt:dt="string">http://www.zotero.org/styles/apa</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_1_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_1_1 dt:dt="string">American Psychological Association 6th edition</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_1_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_2_1 dt:dt="string">http://www.zotero.org/styles/american-sociological-association</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_2_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_2_1 dt:dt="string">American Sociological Association</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_2_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_3_1 dt:dt="string">http://www.zotero.org/styles/bba-molecular-and-cell-biology-of-lipids</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_3_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_3_1 dt:dt="string">BBA - Molecular and Cell Biology of Lipids</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_3_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_4_1 dt:dt="string">http://www.zotero.org/styles/journal-of-endocrinology</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_4_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_4_1 dt:dt="string">Journal of Endocrinology</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_4_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_5_1 dt:dt="string">http://www.zotero.org/styles/molecular-endocrinology</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_5_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_5_1 dt:dt="string">Molecular Endocrinology</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_5_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_6_1 dt:dt="string">http://www.zotero.org/styles/plos-one</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_6_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_6_1 dt:dt="string">PLOS ONE</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_6_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_7_1 dt:dt="string">http://www.zotero.org/styles/scientific-reports</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_7_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_7_1 dt:dt="string">Scientific Reports</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_7_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_8_1 dt:dt="string">http://www.zotero.org/styles/skeletal-muscle</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_8_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_8_1 dt:dt="string">Skeletal Muscle</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_8_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_9_1 dt:dt="string">http://www.zotero.org/styles/the-journal-of-clinical-endocrinology-and-metabolism</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_9_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_9_1 dt:dt="string">The Journal of Clinical Endocrinology &amp; Metabolism</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_9_1>
 </o:CustomDocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=themeData href="PLOS-One%20Response_files/themedata.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:SpellingState>Clean</w:SpellingState>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves/>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>JA</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
   <w:UseFELayout/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="276">
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 9"/>
  <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]--><![if !supportAnnotations]><style id="dynCom" type="text/css"><!-- --></style><script language="JavaScript"><!--function msoCommentShow(anchor_id, com_id){	if(msoBrowserCheck()) 		{		c = document.all(com_id);		if (null != c)			{			a = document.all(anchor_id);			var cw = c.offsetWidth;			var ch = c.offsetHeight;			var aw = a.offsetWidth;			var ah = a.offsetHeight;			var x  = a.offsetLeft;			var y  = a.offsetTop;			var el = a;			while (el.tagName != "BODY") 				{				el = el.offsetParent;				x = x + el.offsetLeft;				y = y + el.offsetTop;				}			var bw = document.body.clientWidth;			var bh = document.body.clientHeight;			var bsl = document.body.scrollLeft;			var bst = document.body.scrollTop;			if (x + cw + ah / 2 > bw + bsl && x + aw - ah / 2 - cw >= bsl ) 				{ c.style.left = x + aw - ah / 2 - cw; }			else 				{ c.style.left = x + ah / 2; }			if (y + ch + ah / 2 > bh + bst && y + ah / 2 - ch >= bst ) 				{ c.style.top = y + ah / 2 - ch; }			else 				{ c.style.top = y + ah / 2; }			c.style.visibility = "visible";}	}	}function msoCommentHide(com_id) {	if(msoBrowserCheck())		{		c = document.all(com_id);		if (null != c)		{		c.style.visibility = "hidden";		c.style.left = -1000;		c.style.top = -1000;		} } }function msoBrowserCheck(){	ms = navigator.appVersion.indexOf("MSIE");	vers = navigator.appVersion.substring(ms + 5, ms + 6);	ie4 = (ms > 0) && (parseInt(vers) >= 4);	return ie4;}if (msoBrowserCheck()){	document.styleSheets.dynCom.addRule(".msocomanchor","background: infobackground");	document.styleSheets.dynCom.addRule(".msocomoff","display: none");	document.styleSheets.dynCom.addRule(".msocomtxt","visibility: hidden");	document.styleSheets.dynCom.addRule(".msocomtxt","position: absolute");	document.styleSheets.dynCom.addRule(".msocomtxt","top: -1000");	document.styleSheets.dynCom.addRule(".msocomtxt","left: -1000");	document.styleSheets.dynCom.addRule(".msocomtxt","width: 33%");	document.styleSheets.dynCom.addRule(".msocomtxt","background: infobackground");	document.styleSheets.dynCom.addRule(".msocomtxt","color: infotext");	document.styleSheets.dynCom.addRule(".msocomtxt","border-top: 1pt solid threedlightshadow");	document.styleSheets.dynCom.addRule(".msocomtxt","border-right: 2pt solid threedshadow");	document.styleSheets.dynCom.addRule(".msocomtxt","border-bottom: 2pt solid threedshadow");	document.styleSheets.dynCom.addRule(".msocomtxt","border-left: 1pt solid threedlightshadow");	document.styleSheets.dynCom.addRule(".msocomtxt","padding: 3pt 3pt 3pt 3pt");}// --></script><![endif]>
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:"Courier New";
	panose-1:2 7 3 9 2 2 5 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Times;
	panose-1:2 0 5 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"\FF2D\FF33 \660E\671D";
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
	{font-family:"\FF2D\FF33 \30B4\30B7\30C3\30AF";
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
	{font-family:"\FF2D\FF33 \30B4\30B7\30C3\30AF";
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-520092929 1073786111 9 0 415 0;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073743103 0 0 415 0;}
@font-face
	{font-family:"Lucida Grande";
	panose-1:2 11 6 0 4 5 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-520090897 1342218751 0 0 447 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"\FF2D\FF33 \660E\671D";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
h1
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 1 Char";
	mso-style-next:Normal;
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"\FF2D\FF33 \30B4\30B7\30C3\30AF";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#345A8A;
	mso-themecolor:accent1;
	mso-themeshade:181;
	mso-font-kerning:0pt;
	font-weight:bold;}
h3
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 3 Char";
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:3;
	font-size:13.5pt;
	font-family:Times;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	font-weight:bold;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Comment Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"\FF2D\FF33 \660E\671D";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;}
p
	{mso-style-priority:99;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Times;
	mso-fareast-font-family:"\FF2D\FF33 \660E\671D";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"Comment Text";
	mso-style-link:"Comment Subject Char";
	mso-style-next:"Comment Text";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"\FF2D\FF33 \660E\671D";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Lucida Grande";
	mso-fareast-font-family:"\FF2D\FF33 \660E\671D";
	mso-fareast-theme-font:minor-fareast;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 3";
	mso-ansi-font-size:13.5pt;
	mso-bidi-font-size:13.5pt;
	font-family:Times;
	mso-ascii-font-family:Times;
	mso-hansi-font-family:Times;
	font-weight:bold;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Comment Text";}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"Comment Text Char";
	mso-style-link:"Comment Subject";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-weight:bold;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Balloon Text";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Lucida Grande";
	mso-ascii-font-family:"Lucida Grande";
	mso-hansi-font-family:"Lucida Grande";
	mso-bidi-font-family:"Lucida Grande";}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 1";
	mso-ansi-font-size:16.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"\FF2D\FF33 \30B4\30B7\30C3\30AF";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#345A8A;
	mso-themecolor:accent1;
	mso-themeshade:181;
	font-weight:bold;}
span.SpellE
	{mso-style-name:"";
	mso-spl-e:yes;}
span.GramE
	{mso-style-name:"";
	mso-gram-e:yes;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"\FF2D\FF33 \660E\671D";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
@list l0
	{mso-list-id:977997040;
	mso-list-template-ids:-233831774;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1027"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=WordSection1>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
style='font-family:"Times New Roman"'>We thank the reviewer and editor for re-considering
our manuscript.<span style="mso-spacerun:yes">&nbsp;&nbsp; </span>We have
substantially modified the manuscript to reflect these comments and suggestions
as described in detail below:<o:p></o:p></span></b></p>

<p class=MsoNormal><span style='font-family:"Times New Roman"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><span style='font-family:"Times New Roman";
color:#333333;mso-bidi-font-style:italic'>Reviewer #1</span><span
style='font-family:"Times New Roman";color:#333333'>: The manuscript
PONE-D-14-30128 entitled “Gene Expression Signature in Adipose Tissue of
Acromegaly Patients” by Hochberg et al. describes the analysis of the adipose
tissue <span class=SpellE>transcriptome</span> form acromegaly patients vs.
non-functioning adenoma patients, which revealed drastic changes in previously
and newly identified targets related to metabolism, insulin and lipid pathways.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><span style='font-family:"Times New Roman";
color:#333333'>The rational of the study seems to be appropriate and well
defined; however there are major study and technical limitations that lessen
the relevance and impact of the study. It seems that the manuscript do not
describe a technically sound piece of scientific research. It is not clear if
the experiments have been conducted rigorously, with appropriate controls,
replication, and sample sizes.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:"Times New Roman";color:#333333'>As described
below, we have provided justification for our modified analysis, taking age
into account, also discussing our choice of controls and replication measures.<span
style="mso-spacerun:yes">&nbsp; </span>We feel that these changes improve the
technical soundness of our work.<span style="mso-spacerun:yes">&nbsp;
</span>Ideally larger sample sizes from less phenotypically variable subjects
would have been obtained, but given the rare nature of this disease and the
lack of data with relative lack of information on effects in human patients our
findings, even if not ideal provide an important dataset for future acromegaly
research.<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><span style='font-family:"Times New Roman";
color:#333333'>Regarding the study design, it seems that non-functioning
pituitary adenoma patients are not the appropriate controls in this study as
they are not normal, healthy controls. Indeed, non-functioning pituitary
adenoma patients can present several hormone dysfunctions and other
comorbidities that could be impacting adipose tissue biology. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:"Times New Roman";color:#333333'>Our opinion
is that the non-secreting adenoma controls are technically a reasonable
control, relative to “normal” controls.<span style="mso-spacerun:yes">&nbsp;
</span>These samples are collected by the same surgeons using the same
techniques and were processed identically. Furthermore these patients, even if
not well age matched, do still have a pituitary tumor so we are controlling for
this factor.<span style="mso-spacerun:yes">&nbsp; </span>Several other
published studies have utilized non-secreting adenomas as a control in similar studies
</span></b><!--[if supportFields]><b style='mso-bidi-font-weight:normal'><span
style='font-family:"Times New Roman";color:#333333'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {
&quot;citationItems&quot; : [ { &quot;id&quot; : &quot;ITEM-1&quot;,
&quot;itemData&quot; : { &quot;DOI&quot; : &quot;10.1530/EJE-10-0583&quot;,
&quot;ISSN&quot; : &quot;1479-683X&quot;, &quot;PMID&quot; :
&quot;20696792&quot;, &quot;abstract&quot; : &quot;OBJECTIVES: To evaluate
whether patients with Cushing's syndrome (CS) had i) changes in coagulative and
fibrinolytic parameters associated with CS activity and ii) higher prevalence
of venous thromboembolic events (VTE). DESIGN: Prospective study conducted on
patients with CS evaluated at diagnosis and 12 months after surgery. PATIENTS
AND METHODS: Forty patients with active CS (36 with Cushing's disease (CD) and 4
with an adrenal adenoma) were evaluated. Forty normal subjects and 70 patients
with non-ACTH-secreting pituitary adenomas served as controls. All patients and
controls underwent an assessment of coagulation and fibrinolysis indexes before
and after surgery. RESULTS: CS patients at baseline had a hypercoagulative
phenotype when compared with normal subjects (activated partial thromboplastin
time (aPTT), fibrinogen, D-Dimer, von Willebrand factor (VWF), plasminogen
activator inhibitor 1 (PAI-1 or SERPINE1), antithrombin III (ATIII or
SERPINC1), P&lt;0.0001, \u03b1(2) antiplasmin, P=0.0004, thrombin-antithrombin
complex (TAT), P=0.01, factor IX (F9), P=0.03). Patients with still active
disease after surgery had higher coagulative parameters than those in remission
(VWF (P&lt;0.0001), PAI-1 (P=0.004), TAT (P=0.0001), ATIII (P=0.0002) and
\u03b1(2) antiplasmin (or SERPINF2; P=0.006)), whereas aPTT levels (P=0.007)
were significantly reduced. VTE occurred in three patients with CD (7.5%): one
had a pulmonary embolism and two patients had a deep venous thrombosis; no
patients submitted to transsphenoidal surgery for non-Cushing's pituitary
adenoma had VTE (P=0.04). CONCLUSIONS: Patients with CS have a procoagulative
phenotype due to cortisol-associated changes in haemostatic and fibrinolytic
markers, leading to increased incidence of VTE. Thromboprophylaxis seems to be
appropriated in patients with active disease, particularly in the postoperative
period.&quot;, &quot;author&quot; : [ { &quot;dropping-particle&quot; : &quot;&quot;,
&quot;family&quot; : &quot;Manetti&quot;, &quot;given&quot; : &quot;Luca&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Bogazzi&quot;, &quot;given&quot; :
&quot;Fausto&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Giovannetti&quot;, &quot;given&quot; : &quot;Clara&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Raffaelli&quot;, &quot;given&quot; :
&quot;Valentina&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Genovesi&quot;, &quot;given&quot; : &quot;Maura&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Pellegrini&quot;, &quot;given&quot; :
&quot;Giovanni&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Ruocco&quot;, &quot;given&quot; : &quot;Lucia&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Iannelli&quot;, &quot;given&quot; :
&quot;Aldo&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Martino&quot;, &quot;given&quot; : &quot;Enio&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; } ], &quot;container-title&quot; :
&quot;European journal of endocrinology / European Federation of Endocrine
Societies&quot;, &quot;id&quot; : &quot;ITEM-1&quot;, &quot;issue&quot; :
&quot;5&quot;, &quot;issued&quot; : { &quot;date-parts&quot; : [ [
&quot;2010&quot;, &quot;11&quot; ] ] }, &quot;page&quot; : &quot;783-91&quot;,
&quot;title&quot; : &quot;Changes in coagulation indexes and occurrence of
venous thromboembolism in patients with Cushing's syndrome: results from a
prospective study before and after surgery.&quot;, &quot;type&quot; :
&quot;article-journal&quot;, &quot;volume&quot; : &quot;163&quot; },
&quot;uris&quot; : [
&quot;http://www.mendeley.com/documents/?uuid=8e8f2b59-24d0-45cb-9c5c-eb13ce5ce1aa&quot;
] }, { &quot;id&quot; : &quot;ITEM-2&quot;, &quot;itemData&quot; : {
&quot;DOI&quot; : &quot;10.1111/j.1365-2362.2012.02721.x&quot;,
&quot;ISSN&quot; : &quot;1365-2362&quot;, &quot;PMID&quot; :
&quot;23083406&quot;, &quot;abstract&quot; : &quot;BACKGROUND: In untreated
acromegaly patients, decreased cognitive functioning is reported to be
associated with the degree of growth hormone (GH) and IGF-1 excess. Whether
previous GH excess or current medical treatment for acromegaly specifically
affects cognition remains unclear. The aim of this study was to compare
cognitive functioning of patients who are treated for acromegaly with patients
with non-functioning pituitary adenomas (NFA). In addition, we assessed the
influence of prolonged medical treatment after initial transsphenoidal surgery
on cognition. DESIGN: In this cross-sectional study, 74 patients participated,
who were treated for acromegaly (n = 50; median [interquartile range] age: 53
[45-65] years) or NFA (n = 24; age: 63 [59-70] years). The NFA patients were
selected for a high likelihood of normal GH secretion based on an IGF-1 z-score
within the normal range (&gt; -2) and zero or one axis substituted. Of the
acromegaly patients, 28 had achieved remission, while 22 were biochemically
controlled with long-acting somatostatin analogues and/or pegvisomant. Memory
and executive functioning were assessed by the 15 Words Test and the Ruff
Figural Fluency Test, and reported as z-scores. RESULTS: The total patient
group scored significantly poorer than the reference population on memory and
executive functioning (P &lt; 0\u00b7001). However, cognitive test performance
was not significantly different between acromegaly patients with a persistent
disease, acromegaly patients in remission and NFA patients. CONCLUSION: The
total patient group scored worse compared with reference populations. We found
no association between previous GH excess and cognition. In addition, current
medical treatment for GH excess in acromegaly was not related to memory and
executive functioning.&quot;, &quot;author&quot; : [ {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Brummelman&quot;, &quot;given&quot; : &quot;Pauline&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Koerts&quot;, &quot;given&quot; :
&quot;Janneke&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Dullaart&quot;, &quot;given&quot; : &quot;Robin P F&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Berg&quot;, &quot;given&quot; :
&quot;Gerrit&quot;, &quot;non-dropping-particle&quot; : &quot;van den&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Tucha&quot;, &quot;given&quot; : &quot;Oliver&quot;, &quot;non-dropping-particle&quot;
: &quot;&quot;, &quot;parse-names&quot; : false, &quot;suffix&quot; :
&quot;&quot; }, { &quot;dropping-particle&quot; : &quot;&quot;,
&quot;family&quot; : &quot;Wolffenbuttel&quot;, &quot;given&quot; : &quot;Bruce
H R&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Beek&quot;, &quot;given&quot; : &quot;Andr\u00e9 P&quot;,
&quot;non-dropping-particle&quot; : &quot;van&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; } ], &quot;container-title&quot; :
&quot;European journal of clinical investigation&quot;, &quot;id&quot; :
&quot;ITEM-2&quot;, &quot;issue&quot; : &quot;12&quot;, &quot;issued&quot; : {
&quot;date-parts&quot; : [ [ &quot;2012&quot;, &quot;12&quot; ] ] }, &quot;page&quot;
: &quot;1317-24&quot;, &quot;title&quot; : &quot;Effects of previous growth
hormone excess and current medical treatment for acromegaly on
cognition.&quot;, &quot;type&quot; : &quot;article-journal&quot;,
&quot;volume&quot; : &quot;42&quot; }, &quot;uris&quot; : [
&quot;http://www.mendeley.com/documents/?uuid=70f87405-f959-472b-8bef-08a836aec53d&quot;
] }, { &quot;id&quot; : &quot;ITEM-3&quot;, &quot;itemData&quot; : {
&quot;DOI&quot; : &quot;10.1210/jc.2010-1253&quot;, &quot;ISSN&quot; :
&quot;1945-7197&quot;, &quot;PMID&quot; : &quot;20843947&quot;,
&quot;abstract&quot; : &quot;OBJECTIVE: Active acromegaly is associated with
psychopathology, personality changes, and cognitive dysfunction. It is unknown
whether, and to what extent, these effects are present after long-term cure of
acromegaly. AIM: The aim of the study was to assess psychopathology,
personality traits, and cognitive function in patients after long-term cure of
acromegaly. DESIGN: This was a cross-sectional study. PATIENTS AND METHODS: We
studied 68 patients after long-term cure (13\u00b11 yr) of acromegaly and 68
matched controls. We compared these data with 60 patients treated for
nonfunctioning pituitary macroadenomas (NFMAs) and 60 matched controls.
Psychopathology was assessed using the Apathy Scale, Irritability Scale,
Hospital Anxiety and Depression Scale, and Mood and Anxiety Symptoms
Questionnaire short-form, and personality was assessed by the Dimensional
Assessment of Personality Pathology short-form (DAPPs). Cognitive function was
assessed by 11 tests. RESULTS: Compared with matched controls, patients cured
from acromegaly scored significantly worse on virtually all psychopathology
questionnaires and on several subscales of the DAPPs. Compared with NFMA
patients, patients cured from acromegaly scored worse on negative affect
(P=0.050) and somatic arousal (P=0.009) and seven of 18 subscales of the DAPPs
(P&lt;0.05). Cognitive function in patients cured from acromegaly did not differ
from matched controls or patients treated for NFMA. CONCLUSION: Patients with
long-term cure of acromegaly show a higher prevalence of psychopathology and
maladaptive personality traits but not cognitive dysfunction, compared with
matched controls and patients treated for NFMA. These results suggest
irreversible effects of previous GH excess, rather than effects of pituitary
adenomas per se and/or their treatment, on the central nervous system.&quot;,
&quot;author&quot; : [ { &quot;dropping-particle&quot; : &quot;&quot;,
&quot;family&quot; : &quot;Tiemensma&quot;, &quot;given&quot; :
&quot;Jitske&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; : &quot;Biermasz&quot;,
&quot;given&quot; : &quot;Nienke R&quot;, &quot;non-dropping-particle&quot; :
&quot;&quot;, &quot;parse-names&quot; : false, &quot;suffix&quot; :
&quot;&quot; }, { &quot;dropping-particle&quot; : &quot;&quot;,
&quot;family&quot; : &quot;Mast&quot;, &quot;given&quot; : &quot;Roos C&quot;,
&quot;non-dropping-particle&quot; : &quot;van der&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Wassenaar&quot;, &quot;given&quot; : &quot;Moniek J E&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; : false,
&quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Middelkoop&quot;, &quot;given&quot; :
&quot;Huub A M&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Pereira&quot;, &quot;given&quot; : &quot;Alberto M&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Romijn&quot;, &quot;given&quot; :
&quot;Johannes A&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; } ],
&quot;container-title&quot; : &quot;The Journal of clinical endocrinology and
metabolism&quot;, &quot;id&quot; : &quot;ITEM-3&quot;, &quot;issue&quot; :
&quot;12&quot;, &quot;issued&quot; : { &quot;date-parts&quot; : [ [
&quot;2010&quot;, &quot;12&quot; ] ] }, &quot;page&quot; :
&quot;E392-402&quot;, &quot;title&quot; : &quot;Increased psychopathology and
maladaptive personality traits, but normal cognitive functioning, in patients
after long-term cure of acromegaly.&quot;, &quot;type&quot; :
&quot;article-journal&quot;, &quot;volume&quot; : &quot;95&quot; },
&quot;uris&quot; : [
&quot;http://www.mendeley.com/documents/?uuid=005682c8-09ef-4dd0-8f17-13738c2e5c25&quot;
] }, { &quot;id&quot; : &quot;ITEM-4&quot;, &quot;itemData&quot; : {
&quot;DOI&quot; : &quot;10.1007/s12020-013-0106-9&quot;, &quot;ISSN&quot; :
&quot;1559-0100&quot;, &quot;PMID&quot; : &quot;24282035&quot;,
&quot;abstract&quot; : &quot;Pituitary adenomas (PAs) represent 15 % of all
brain tumors. One-sixth of these are reported to cause acromegaly via excess
growth hormone secretion. These tumors have been associated with multiple
comorbidities, including neuropsychiatric and cognitive dysfunction. We aimed
to assess patient perception of cognitive deficits and the relationship of
cognitive changes to active acromegaly (AA) versus controlled acromegaly (CA)
versus non-functional PAs (NFPA). A modified FACT-Cog survey was used, which
focused on the prevalence and severity of perceived dysfunction in five areas
of cognitive function: ability to learn, concentration/distractibility, mental
agility, memory and recall, and verbal recall. Patient perception of current
health and health change over the previous 12 months was also assessed. The
overall perceived prevalence and severity of cognitive dysfunction were the
highest among NFPA groups, particularly in the areas of mental agility, verbal
recall, and memory/recall. Patients with AA reported greater prevalence and
severity of dysfunction with respect to concentration/distractibility and
ability to learn. Patients with AA reported the best overall current health,
though patients with CA reported the greatest improvement in health over the
previous year. These findings may indicate that PAs can affect cognitive
function regardless of whether excess growth hormone is present. Acromegaly and
NFPA patients perceive specific areas of cognitive dysfunction that may require
further evaluation and treatment. Further research may be useful regarding
patient quality of life, patient functionality during normal daily activities,
and perceived dysfunction despite biological disease control.&quot;,
&quot;author&quot; : [ { &quot;dropping-particle&quot; : &quot;&quot;,
&quot;family&quot; : &quot;Yedinak&quot;, &quot;given&quot; : &quot;Chris
G&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Fleseriu&quot;, &quot;given&quot; : &quot;Maria&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; } ], &quot;container-title&quot; :
&quot;Endocrine&quot;, &quot;id&quot; : &quot;ITEM-4&quot;, &quot;issue&quot; :
&quot;3&quot;, &quot;issued&quot; : { &quot;date-parts&quot; : [ [
&quot;2014&quot;, &quot;8&quot; ] ] }, &quot;page&quot; : &quot;585-93&quot;,
&quot;title&quot; : &quot;Self-perception of cognitive function among patients
with active acromegaly, controlled acromegaly, and non-functional pituitary
adenoma: a pilot study.&quot;, &quot;type&quot; : &quot;article-journal&quot;,
&quot;volume&quot; : &quot;46&quot; }, &quot;uris&quot; : [
&quot;http://www.mendeley.com/documents/?uuid=ccd9f726-68f6-456f-84ef-7b5ab8385909&quot;
] } ], &quot;mendeley&quot; : { &quot;previouslyFormattedCitation&quot; :
&quot;[1\u20134]&quot; }, &quot;properties&quot; : { &quot;noteIndex&quot; : 0
}, &quot;schema&quot; :
&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;
}<span style='mso-element:field-separator'></span></span></b><![endif]--><span
style='font-family:"Times New Roman";color:#333333;mso-no-proof:yes'>[1&#8211;4]</span><!--[if supportFields]><b
style='mso-bidi-font-weight:normal'><span style='font-family:"Times New Roman";
color:#333333'><span style='mso-element:field-end'></span></span></b><![endif]--><b
style='mso-bidi-font-weight:normal'><span style='font-family:"Times New Roman";
color:#333333'>.<span style="mso-spacerun:yes">&nbsp; </span>To the concern
that the non-functioning adenoma is phenotypically altering the physiology of
these patients we propose to both mention this as a potential issue we have
mentioned this as a caveat in the discussion with the following text:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:12.0pt;
margin-left:.5in'><b style='mso-bidi-font-weight:normal'><span
style='font-family:"Times New Roman";color:red'>One potential caveat to our
approach is the use of patients with a non-secreting adenoma as the control
group.<span style="mso-spacerun:yes">&nbsp; </span>To avoid the possible
effects of hypopituitarism on adipose tissue we excluded patients with
pituitary hormone deficiencies. We chose to include this as the control group
as these samples not only collected in an identical manner from the same
surgeons and processed identically, but also controls for potential
non-secreting effects of pituitary tumor growths in the acromegaly subjects.<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><span style='font-family:"Times New Roman";
color:#333333'>In addition, the patients and controls are not age matched<span
class=GramE>;</span> while age has been shown to influence adipose tissue
biology. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:"Times New Roman";color:#333333'>The reviewer
brings up an excellent point, as the previous analysis did not match the
samples for age.<span style="mso-spacerun:yes">&nbsp; </span>To directly
address this, we performed an additional supplementary analysis of the data
wherein we separated the samples into subjects whom were under or at least 60
years of age and repeated the analysis.<span style="mso-spacerun:yes">&nbsp;
</span>This is described in the methods section as such:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:12.0pt;
margin-left:.5in'><b style='mso-bidi-font-weight:normal'><span
style='font-family:"Times New Roman";color:red'>To account for potential
age-dependent changes in the subjects, we separated the patients into two
groups, based on the median value, <span class=GramE>under</span> 60 years of
age versus 60 and above. We then added this age group as a covariate along with
the disease state. We tested for interactions between the age group and the
disease state for each gene and did not identify any interaction term after
adjusting for multiple observations (q&lt;0.05).<span
style="mso-spacerun:yes">&nbsp; </span>All fold changes provided in this
manuscript are age-adjusted fold change values calculated from this regression.<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:"Times New Roman";color:#333333'>After this
analysis we found that after controlling for age, we observed 418 genes that
were significantly different between acromegaly and control patients. We have
provided a new Supplementary Tables 2-4 describing these data, and their
associated pathway analyses.<span style="mso-spacerun:yes">&nbsp; </span>We
also tested whether there were age-dependent differences in either our control
or <span class=SpellE>acromegalic</span> groups and found 1 significantly
different gene in the <span class=SpellE>acromegalic</span> group and none
within the control group.<span style="mso-spacerun:yes">&nbsp; </span>This is
now described in the results section with updated p-values adjusting for the age
differences.<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:"Times New Roman"'>As the reviewer suspected, some
previously reported genes and pathways were no longer significantly different
after this adjustment, and therefore the results section has been re-written,
only taking into account only the age-adjusted fold changes and q-values.<span
style="mso-spacerun:yes">&nbsp;&nbsp; </span>We feel that this change in
analysis improved the reliability of our data, since we observed only a small
decrease in the total number of statistically significant genes, but the number
of statistically significant pathways identified by GSEA analysis was
dramatically increased.<span style="mso-spacerun:yes">&nbsp; </span>This
suggests that the genes that are enriched by the age-adjusted analysis cluster
in pathway-specific modules, strengthening the biological relevance of our
data. <span style="mso-spacerun:yes">&nbsp;&nbsp;</span><o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><span style='font-family:"Times New Roman";
color:#333333'>Furthermore, it is not clear if the authors had into account the
acromegaly onset, which is crucial to determine the time of high GH exposure.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:"Times New Roman"'>As acromegaly is a very
slow disease, with a delay of diagnosis of about 10 years in average, we cannot
know the exact onset of disease. Exposure to excess growth hormone has most
likely been for several years prior to the collection of the biopsy.<span
style="mso-spacerun:yes">&nbsp; </span><o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:"Times New Roman"'>Our two older acromegaly
patients also had the mildest disease, with lower IGF1 levels, so we cannot
discriminate if their milder gene expression change is secondary to lower
GH/IGF1 levels or due to their age. This is mentioned in the results as
follows:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:12.0pt;
margin-left:35.45pt;tab-stops:right 42.55pt'><b><span style='font-family:"Times New Roman";
color:red'>Note that the older subjects had lower serum IGF-1 than the younger
subjects, indicating that circulating IGF-1 levels may correlate with generally
reduced transcriptional changes observed in the older <span class=SpellE>acromegalic</span>
patients (Figure 3C).<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:"Times New Roman"'>Consistent with this, we
found that the magnitude of the differences between older and younger <span
class=SpellE>acromegalics</span> tended to also be smaller.<span
style="mso-spacerun:yes">&nbsp; </span>Again, whether this is due to duration
of exposure, or age-dependent differences in the disease cannot be determined
from these studies.<span style="mso-spacerun:yes">&nbsp; </span>This is
mentioned in the discussion as follows:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-left:.5in;text-align:justify;text-justify:
inter-ideograph'><b style='mso-bidi-font-weight:normal'><span style='font-family:
"Times New Roman";color:red'>Interestingly, we observed more modest gene
expression changes in general for older <span class=SpellE>acromegalic</span>
patients than for younger patients.<span style="mso-spacerun:yes">&nbsp;
</span>We are unable to determine from our study how long patients were <span
class=SpellE>acromegalic</span> prior to our study, so one possibility is that
the older patients have had longer to adapt to elevated GH levels.<span
style="mso-spacerun:yes">&nbsp; </span>Alternatively, elevated GH/IGF-1
signaling may play a stronger role in younger patients.<span
style="mso-spacerun:yes">&nbsp; </span><o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:"Times New Roman"'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><span style='font-family:"Times New Roman";
color:#333333'>Regarding the experimental approach, it seems that the authors
did not further validate the <span class=SpellE>transcriptomic</span> analysis
by <span class=SpellE>qPCR</span> or western-blot, which drastically lessen the
reliability of the results. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:"Times New Roman";color:#333333'>To address
the reproducibility of our findings, we have extensively compared our findings
to published data both from single gene studies and from microarray studies on
tissue culture cells.<span style="mso-spacerun:yes">&nbsp; </span>Neither of
these <span class=GramE>are</span> as broad in scope as our findings, but we
have found good correlations between our findings and those of others in most
cases, importantly for<i style='mso-bidi-font-style:normal'>, IGF1, PTPN3,
SOCS2, CISH, LPL </i>and<i style='mso-bidi-font-style:normal'> HSD11B1</i>.<span
style="mso-spacerun:yes">&nbsp; </span>In cases where we have not observed
similar gene expression changes as proposed in the published literature we have
discussed these as well, such as for <i style='mso-bidi-font-style:normal'>PIK3R1.<span
style="mso-spacerun:yes">&nbsp; </span></i>These independent descriptions
provide solid validation for the reliability of our data.<span
style="mso-spacerun:yes">&nbsp; </span><o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:"Times New Roman";color:#333333'>We had
considered performing <span class=SpellE>qPCR</span> studies to ‘re-validate’
some of our gene-expression findings but there is little evidence that <span
class=SpellE>qPCR</span> analyses from the same samples will add any extra
validity to our data so we decided to eschew those experiments.<span
style="mso-spacerun:yes">&nbsp; </span>Previous studies have shown extremely close
correlations between <span class=SpellE>qPCR</span> and <span class=SpellE>RNAseq</span>
data </span></b><!--[if supportFields]><b style='mso-bidi-font-weight:normal'><span
style='font-family:"Times New Roman";color:#333333'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {
&quot;citationItems&quot; : [ { &quot;id&quot; : &quot;ITEM-1&quot;,
&quot;itemData&quot; : { &quot;DOI&quot; : &quot;10.1038/nmeth.1503&quot;,
&quot;ISSN&quot; : &quot;1548-7105&quot;, &quot;PMID&quot; :
&quot;20835245&quot;, &quot;abstract&quot; : &quot;In alternative expression
analysis by sequencing (ALEXA-seq), we developed a method to analyze massively
parallel RNA sequence data to catalog transcripts and assess differential and
alternative expression of known and predicted mRNA isoforms in cells and
tissues. As proof of principle, we used the approach to compare
fluorouracil-resistant and -nonresistant human colorectal cancer cell lines. We
assessed the sensitivity and specificity of the approach by comparison to exon
tiling and splicing microarrays and validated the results with reverse transcription-PCR,
quantitative PCR and Sanger sequencing. We observed global disruption of
splicing in fluorouracil-resistant cells characterized by expression of new
mRNA isoforms resulting from exon skipping, alternative splice site usage and
intron retention. Alternative expression annotation databases, source code, a
data viewer and other resources to facilitate analysis are available at
http://www.alexaplatform.org/alexa_seq/.&quot;, &quot;author&quot; : [ {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Griffith&quot;, &quot;given&quot; : &quot;Malachi&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Griffith&quot;, &quot;given&quot; :
&quot;Obi L&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; : &quot;Mwenifumbo&quot;,
&quot;given&quot; : &quot;Jill&quot;, &quot;non-dropping-particle&quot; :
&quot;&quot;, &quot;parse-names&quot; : false, &quot;suffix&quot; :
&quot;&quot; }, { &quot;dropping-particle&quot; : &quot;&quot;,
&quot;family&quot; : &quot;Goya&quot;, &quot;given&quot; : &quot;Rodrigo&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Morrissy&quot;, &quot;given&quot; :
&quot;a Sorana&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Morin&quot;, &quot;given&quot; : &quot;Ryan D&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Corbett&quot;, &quot;given&quot; :
&quot;Richard&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Tang&quot;, &quot;given&quot; : &quot;Michelle J&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Hou&quot;, &quot;given&quot; :
&quot;Ying-Chen&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Pugh&quot;, &quot;given&quot; : &quot;Trevor J&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Robertson&quot;, &quot;given&quot; :
&quot;Gordon&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Chittaranjan&quot;, &quot;given&quot; : &quot;Suganthi&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Ally&quot;, &quot;given&quot; :
&quot;Adrian&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Asano&quot;, &quot;given&quot; : &quot;Jennifer K&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Chan&quot;, &quot;given&quot; :
&quot;Susanna Y&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Li&quot;, &quot;given&quot; : &quot;Haiyan I&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;McDonald&quot;, &quot;given&quot; :
&quot;Helen&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Teague&quot;, &quot;given&quot; : &quot;Kevin&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Zhao&quot;, &quot;given&quot; :
&quot;Yongjun&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Zeng&quot;, &quot;given&quot; : &quot;Thomas&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Delaney&quot;, &quot;given&quot; :
&quot;Allen&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Hirst&quot;, &quot;given&quot; : &quot;Martin&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Morin&quot;, &quot;given&quot; :
&quot;Gregg B&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Jones&quot;, &quot;given&quot; : &quot;Steven J M&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Tai&quot;, &quot;given&quot; :
&quot;Isabella T&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; : &quot;Marra&quot;,
&quot;given&quot; : &quot;Marco a&quot;, &quot;non-dropping-particle&quot; :
&quot;&quot;, &quot;parse-names&quot; : false, &quot;suffix&quot; :
&quot;&quot; } ], &quot;container-title&quot; : &quot;Nature methods&quot;,
&quot;id&quot; : &quot;ITEM-1&quot;, &quot;issue&quot; : &quot;10&quot;,
&quot;issued&quot; : { &quot;date-parts&quot; : [ [ &quot;2010&quot;,
&quot;10&quot; ] ] }, &quot;page&quot; : &quot;843-7&quot;, &quot;title&quot; :
&quot;Alternative expression analysis by RNA sequencing.&quot;,
&quot;type&quot; : &quot;article-journal&quot;, &quot;volume&quot; :
&quot;7&quot; }, &quot;uris&quot; : [ &quot;http://www.mendeley.com/documents/?uuid=8873b5ef-92bb-42bd-8991-de7e11ea8e1c&quot;
] }, { &quot;id&quot; : &quot;ITEM-2&quot;, &quot;itemData&quot; : {
&quot;DOI&quot; : &quot;10.1186/1471-2164-10-531&quot;, &quot;ISSN&quot; :
&quot;1471-2164&quot;, &quot;PMID&quot; : &quot;19917133&quot;,
&quot;abstract&quot; : &quot;BACKGROUND: Massive parallel sequencing has the
potential to replace microarrays as the method for transcriptome profiling.
Currently there are two protocols: full-length RNA sequencing (RNA-SEQ) and
3'-tag digital gene expression (DGE). In this preliminary effort, we evaluated
the 3' DGE approach using two reference RNA samples from the MicroArray Quality
Control Consortium (MAQC).\n\nRESULTS: Using Brain RNA sample from multiple
runs, we demonstrated that the transcript profiles from 3' DGE were highly
reproducible between technical and biological replicates from libraries
constructed by the same lab and even by different labs, and between two
generations of Illumina's Genome Analyzers. Approximately 65% of all sequence
reads mapped to mitochondrial genes, ribosomal RNAs, and canonical transcripts.
The expression profiles of brain RNA and universal human reference RNA were
compared which demonstrated that DGE was also highly quantitative with
excellent correlation of differential expression with quantitative real-time
PCR. Furthermore, one lane of 3' DGE sequencing, using the current sequencing
chemistry and image processing software, had wider dynamic range for
transcriptome profiling and was able to detect lower expressed genes which are
normally below the detection threshold of microarrays.\n\nCONCLUSION: 3' tag
DGE profiling with massive parallel sequencing achieved high sensitivity and
reproducibility for transcriptome profiling. Although it lacks the ability of
detecting alternative splicing events compared to RNA-SEQ, it is much more
affordable and clearly out-performed microarrays (Affymetrix) in detecting
lower abundant transcripts.&quot;, &quot;author&quot; : [ {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Asmann&quot;, &quot;given&quot; : &quot;Yan W&quot;, &quot;non-dropping-particle&quot;
: &quot;&quot;, &quot;parse-names&quot; : false, &quot;suffix&quot; :
&quot;&quot; }, { &quot;dropping-particle&quot; : &quot;&quot;,
&quot;family&quot; : &quot;Klee&quot;, &quot;given&quot; : &quot;Eric W&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Thompson&quot;, &quot;given&quot; :
&quot;E Aubrey&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Perez&quot;, &quot;given&quot; : &quot;Edith a&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Middha&quot;, &quot;given&quot; :
&quot;Sumit&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Oberg&quot;, &quot;given&quot; : &quot;Ann L&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Therneau&quot;, &quot;given&quot; :
&quot;Terry M&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Smith&quot;, &quot;given&quot; : &quot;David I&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Poland&quot;, &quot;given&quot; :
&quot;Gregory a&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Wieben&quot;, &quot;given&quot; : &quot;Eric D&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Kocher&quot;, &quot;given&quot; :
&quot;Jean-Pierre a&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; } ],
&quot;container-title&quot; : &quot;BMC genomics&quot;, &quot;id&quot; : &quot;ITEM-2&quot;,
&quot;issued&quot; : { &quot;date-parts&quot; : [ [ &quot;2009&quot;,
&quot;1&quot; ] ] }, &quot;page&quot; : &quot;531&quot;, &quot;title&quot; :
&quot;3' tag digital gene expression profiling of human brain and universal
reference RNA using Illumina Genome Analyzer.&quot;, &quot;type&quot; :
&quot;article-journal&quot;, &quot;volume&quot; : &quot;10&quot; },
&quot;uris&quot; : [ &quot;http://www.mendeley.com/documents/?uuid=4efa0648-cffa-4246-b478-cab4490cbf38&quot;
] }, { &quot;id&quot; : &quot;ITEM-3&quot;, &quot;itemData&quot; : {
&quot;DOI&quot; : &quot;10.1038/nmeth.2694&quot;, &quot;ISSN&quot; :
&quot;1548-7105&quot;, &quot;PMID&quot; : &quot;24141493&quot;,
&quot;abstract&quot; : &quot;Interest in single-cell whole-transcriptome
analysis is growing rapidly, especially for profiling rare or heterogeneous
populations of cells. We compared commercially available single-cell RNA
amplification methods with both microliter and nanoliter volumes, using
sequence from bulk total RNA and multiplexed quantitative PCR as benchmarks to
systematically evaluate the sensitivity and accuracy of various single-cell
RNA-seq approaches. We show that single-cell RNA-seq can be used to perform
accurate quantitative transcriptome measurement in individual cells with a
relatively small number of sequencing reads and that sequencing large numbers
of single cells can recapitulate bulk transcriptome complexity.&quot;,
&quot;author&quot; : [ { &quot;dropping-particle&quot; : &quot;&quot;,
&quot;family&quot; : &quot;Wu&quot;, &quot;given&quot; : &quot;Angela R&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Neff&quot;, &quot;given&quot; :
&quot;Norma F&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Kalisky&quot;, &quot;given&quot; : &quot;Tomer&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Dalerba&quot;, &quot;given&quot; :
&quot;Piero&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Treutlein&quot;, &quot;given&quot; : &quot;Barbara&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Rothenberg&quot;, &quot;given&quot; :
&quot;Michael E&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Mburu&quot;, &quot;given&quot; : &quot;Francis M&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; : false,
&quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Mantalas&quot;, &quot;given&quot; :
&quot;Gary L&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Sim&quot;, &quot;given&quot; : &quot;Sopheak&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Clarke&quot;, &quot;given&quot; :
&quot;Michael F&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Quake&quot;, &quot;given&quot; : &quot;Stephen R&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; } ], &quot;container-title&quot; :
&quot;Nature methods&quot;, &quot;id&quot; : &quot;ITEM-3&quot;,
&quot;issue&quot; : &quot;1&quot;, &quot;issued&quot; : {
&quot;date-parts&quot; : [ [ &quot;2014&quot;, &quot;1&quot; ] ] },
&quot;page&quot; : &quot;41-6&quot;, &quot;title&quot; : &quot;Quantitative
assessment of single-cell RNA-sequencing methods.&quot;, &quot;type&quot; :
&quot;article-journal&quot;, &quot;volume&quot; : &quot;11&quot; },
&quot;uris&quot; : [
&quot;http://www.mendeley.com/documents/?uuid=ac508b4f-e00d-4d7d-910d-5d145b6c4426&quot;
] }, { &quot;id&quot; : &quot;ITEM-4&quot;, &quot;itemData&quot; : {
&quot;DOI&quot; : &quot;10.1016/j.gene.2014.01.031&quot;, &quot;ISSN&quot; :
&quot;1879-0038&quot;, &quot;PMID&quot; : &quot;24440293&quot;,
&quot;abstract&quot; : &quot;Differential growth of the pearl oyster Pinctada
fucata still exists in the aquaculture production. There is no systematic study
of the entire transcriptome of differential gene expression in P. fucata in the
literature. In this study, high-throughput Illumina/HiSeq\u2122 2000 RNA-Seq
was used to examine the differences of gene expression in large (L) and small
oysters (S). In total, 74,293 and 76,635 unigenes were generated from L and S
oysters, respectively. RT quantitative PCR (qPCR) analysis showed that the
differential expression pattern of 19 out of 34 selected genes was consistent
with the results of RNA-Seq analysis: 14 genes (11 for growth, 1 for
reproduction and 2 for shell formation) were expressed more highly in S, 5
genes (1 for growth, 1 for reproduction and 3 for the immune system) were
expressed more highly in L; 3 genes associated with the immune system were
opposite to it; and no difference was found for the remaining 12 genes. Another
9 shell formation-related genes in L and S were examined by qPCR: 1 gene was
expressed more highly in L, 5 genes were expressed more highly in S and no
difference was found for the remaining 3 genes. Some genes related to growth
and development, shell formation and reproduction were expressed more highly in
S compared to L. This phenomenon could be explained by \&quot;catch-up
growth\&quot;. The results of this study will help toward a comprehensive
understanding of the complexity of differential growth between P. fucata individuals
and provide valuable information for future research.&quot;, &quot;author&quot;
: [ { &quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Shi&quot;, &quot;given&quot; : &quot;Yu&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;He&quot;, &quot;given&quot; :
&quot;Maoxian&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; } ],
&quot;container-title&quot; : &quot;Gene&quot;, &quot;id&quot; :
&quot;ITEM-4&quot;, &quot;issue&quot; : &quot;2&quot;, &quot;issued&quot; : {
&quot;date-parts&quot; : [ [ &quot;2014&quot;, &quot;4&quot;, &quot;1&quot; ] ]
}, &quot;page&quot; : &quot;313-22&quot;, &quot;publisher&quot; :
&quot;Elsevier B.V.&quot;, &quot;title&quot; : &quot;Differential gene
expression identified by RNA-Seq and qPCR in two sizes of pearl oyster
(Pinctada fucata).&quot;, &quot;type&quot; : &quot;article-journal&quot;,
&quot;volume&quot; : &quot;538&quot; }, &quot;uris&quot; : [ &quot;http://www.mendeley.com/documents/?uuid=d6a7b379-a2c4-4bdf-9f8f-3e3625058fc9&quot;
] } ], &quot;mendeley&quot; : { &quot;previouslyFormattedCitation&quot; :
&quot;[5\u20138]&quot; }, &quot;properties&quot; : { &quot;noteIndex&quot; : 0
}, &quot;schema&quot; :
&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;
}<span style='mso-element:field-separator'></span></span></b><![endif]--><span
style='font-family:"Times New Roman";color:#333333;mso-no-proof:yes'>[5&#8211;8]</span><!--[if supportFields]><b
style='mso-bidi-font-weight:normal'><span style='font-family:"Times New Roman";
color:#333333'><span style='mso-element:field-end'></span></span></b><![endif]--><b
style='mso-bidi-font-weight:normal'><span style='font-family:"Times New Roman";
color:#333333'>. <span style="mso-spacerun:yes">&nbsp;</span>Ideally, we would
re-validate our findings in a separate cohort of <span class=SpellE>acromegalic</span>
patients, but due to the difficulty in accessing these samples, those
experiments are not possible at this time.<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><span style='font-family:"Times New Roman";
color:#333333'>It is neither <span class=GramE>clear</span> why only 7 out of 9
patients were used for the study. In addition, the study lacks mechanistic
studies and/or validations that <span class=GramE>confirms</span> the direct
action of GH on the analyzed genes.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:12.0pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:"Times New Roman";color:#333333'>The missing
two patients for whom we had phenotypic data but not <span class=SpellE>RNAseq</span>
data were included in Figure 1 but not other analyses.<span
style="mso-spacerun:yes">&nbsp; </span>This was described in the methods
section:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:12.0pt;
margin-left:.5in'><b style='mso-bidi-font-weight:normal'><span
style='font-family:"Times New Roman";color:red'>These subjects corresponded to
the patients described in Table 1, with the exception of subjects 29 and 31
(both acromegaly patients), which had clinical data but no <span class=SpellE>RNAseq</span>
data.<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:12.0pt;margin-right:0in;margin-bottom:
12.0pt;margin-left:0in;mso-outline-level:3'><a
name=user-content-other-comments></a><span style='font-size:15.0pt;font-family:
"Times New Roman";mso-fareast-font-family:"Times New Roman";color:#333333;
mso-bidi-font-weight:bold'>Other comments:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='color:#333333;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;mso-list:l0 level1 lfo1;tab-stops:list .5in'><span class=GramE><span
     style='font-family:"Times New Roman";mso-fareast-font-family:"Times New Roman"'>Several
     of the results presented herein (glucose levels, insulin levels, <span
     class=SpellE>lipolytic</span> measurements) have been previously published
     by other</span></span><span style='font-family:"Times New Roman";
     mso-fareast-font-family:"Times New Roman"'>. However, some of them did not
     reach statistical significance herein, reflecting the fact that the number
     of patients and/or replicates could be too low to draw consistent
     conclusions.<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
margin-left:.5in'><b style='mso-bidi-font-weight:normal'><span
style='font-family:"Times New Roman";mso-fareast-font-family:"Times New Roman";
color:#333333'>As acromegaly is such a rare disease (60 out of 1 000 <span
class=SpellE>000</span>; </span></b><!--[if supportFields]><b style='mso-bidi-font-weight:
normal'><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman";color:#333333'><span style='mso-element:field-begin;
mso-field-lock:yes'></span>ADDIN CSL_CITATION { &quot;citationItems&quot; : [ {
&quot;id&quot; : &quot;ITEM-1&quot;, &quot;itemData&quot; : { &quot;DOI&quot; :
&quot;10.1136/pgmj.2005.036087&quot;, &quot;ISSN&quot; : &quot;1469-0756&quot;,
&quot;PMID&quot; : &quot;16397076&quot;, &quot;abstract&quot; : &quot;Growth
hormone (GH) is synthesised and secreted by the somatotroph cells of the
anterior lobe of the pituitary gland. Its actions involve multiple organs and
systems, affecting postnatal longitudinal growth as well as protein, lipid, and
carbohydrate metabolism. GH hypersecretion results in gigantism or acromegaly,
a condition associated with significant morbidity and mortality, while GH
deficiency results in growth retardation in children and the GH deficiency
syndrome in adults. This article, aimed at non-paediatric physicians, examines
the clinical features, diagnosis, and current concepts in the management of
these conditions.&quot;, &quot;author&quot; : [ { &quot;dropping-particle&quot;
: &quot;&quot;, &quot;family&quot; : &quot;Ayuk&quot;, &quot;given&quot; :
&quot;J&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Sheppard&quot;, &quot;given&quot; : &quot;M C&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; } ], &quot;container-title&quot; :
&quot;Postgraduate medical journal&quot;, &quot;id&quot; : &quot;ITEM-1&quot;,
&quot;issue&quot; : &quot;963&quot;, &quot;issued&quot; : {
&quot;date-parts&quot; : [ [ &quot;2006&quot;, &quot;1&quot; ] ] },
&quot;page&quot; : &quot;24-30&quot;, &quot;title&quot; : &quot;Growth hormone
and its disorders.&quot;, &quot;type&quot; : &quot;article-journal&quot;,
&quot;volume&quot; : &quot;82&quot; }, &quot;uris&quot; : [
&quot;http://www.mendeley.com/documents/?uuid=40b421d4-1554-4748-a4f4-350831c40582&quot;
] } ], &quot;mendeley&quot; : { &quot;manualFormatting&quot; : &quot;Ayuk &amp;
Sheppard, 2006)&quot;, &quot;previouslyFormattedCitation&quot; :
&quot;[9]&quot; }, &quot;properties&quot; : { &quot;noteIndex&quot; : 0 },
&quot;schema&quot; :
&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;
}<span style='mso-element:field-separator'></span></span></b><![endif]--><b
style='mso-bidi-font-weight:normal'><span style='font-family:"Times New Roman";
mso-fareast-font-family:"Times New Roman";color:#333333'><span
style='mso-no-proof:yes'>Ayuk &amp; Sheppard, 2006)</span></span></b><!--[if supportFields]><b
style='mso-bidi-font-weight:normal'><span style='font-family:"Times New Roman";
mso-fareast-font-family:"Times New Roman";color:#333333'><span
style='mso-element:field-end'></span></span></b><![endif]--><b
style='mso-bidi-font-weight:normal'><span style='font-family:"Times New Roman";
mso-fareast-font-family:"Times New Roman";color:#333333'>, it was a challenge
to recruit even the 9 patients used in our study.<span
style="mso-spacerun:yes">&nbsp; </span>Due to the heterogeneity in age, body
type and natural history of these patients, it was not surprising that there were
large variances in our samples. We did however reproduce previously described
effects of acromegaly on height, fasting glucose, fasting insulin and HOMA-IR
score and nearly observed statistical significance for isoproterenol-induced
lipolysis in adipose tissue extracts (p=0.058).<span
style="mso-spacerun:yes">&nbsp; </span>Our interpretation of these findings is
that our subject pool is a reasonable phenotypic pool to interpret our
molecular findings.<span style="mso-spacerun:yes">&nbsp; </span>Due to the lack
of molecular findings associated with acromegaly, and our attempts to control
for confounding factors such as age we feel that these data are a valuable
contribution to the molecular phenotype of <span class=SpellE>acromegalic</span>
adipose tissue.<span style="mso-spacerun:yes">&nbsp; </span><o:p></o:p></span></b></p>

<ul type=disc>
 <li class=MsoNormal style='color:#333333;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;mso-list:l0 level1 lfo1;tab-stops:list .5in'><span style='font-family:
     "Times New Roman";mso-fareast-font-family:"Times New Roman"'>It is
     surprising that the authors suggest adipose tissue relevant contribution
     to IGF plasma levels based on a mere correlation. Have the authors determined
     which is the real contribution of adipose tissue to IGF levels?<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
margin-left:.5in'><b style='mso-bidi-font-weight:normal'><span
style='font-family:"Times New Roman";mso-fareast-font-family:"Times New Roman";
color:#333333'>We have speculated as to a role for adipose tissue in IGF1
production, but as the reviewer correctly points out, a direct assessment of
the role of adipose tissue IGF1 to total serum IGF1 would require an adipose
tissue specific <i style='mso-bidi-font-style:normal'>Igf1</i> knockout model,
which is beyond the scope of these studies.<span
style="mso-spacerun:yes">&nbsp; </span>This is described in the results
section:<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
margin-left:1.0in'><b style='mso-bidi-font-weight:normal'><span
style='font-family:"Times New Roman";mso-fareast-font-family:"Times New Roman";
color:red'>Serum IGF1 is primarily thought to be derived from liver tissue due
to the observation that serum IGF-1 levels are reduced 75% in a liver specific
IGF-1 <span class=GramE>knockout<span style="mso-spacerun:yes">&nbsp; </span></span></span></b><!--[if supportFields]><b
style='mso-bidi-font-weight:normal'><span style='font-family:"Times New Roman";
mso-fareast-font-family:"Times New Roman";color:red'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {
&quot;citationItems&quot; : [ { &quot;id&quot; : &quot;ITEM-1&quot;,
&quot;itemData&quot; : { &quot;ISSN&quot; : &quot;0012-1797&quot;,
&quot;PMID&quot; : &quot;14514630&quot;, &quot;abstract&quot; : &quot;Liver
IGF-1 deficient (LID) mice demonstrate a 75% reduction in circulating IGF-1
levels and a corresponding fourfold increase in growth hormone (GH) levels. At
16 weeks of age, LID mice demonstrate, using the hyperinsulinemic-euglycemic
clamp, insulin insensitivity in muscle, liver, and fat tissues. In contrast,
mice with a gene deletion of the acid-labile subunit (ALSKO) demonstrate a 65%
reduction in circulating IGF-1 levels, with normal GH levels and no signs of
insulin resistance. To further clarify the relative roles of increased GH and
decreased IGF-1 levels in the development of insulin resistance, we crossed the
two mouse lines and created a double knockout mouse (LID+ALSKO). LID+ALSKO mice
demonstrate a further reduction in circulating IGF-1 levels (85%) and a
concomitant 10-fold increase in GH levels. Insulin tolerance tests showed an
improvement in insulin responsiveness in the LID+ALSKO mice compared with
controls; LID mice were very insulin insensitive. Surprisingly, insulin
sensitivity, while improved in white adipose tissue and in muscle, was unchanged
in the liver. The lack of improvement in liver insulin sensitivity may reflect
the absence of IGF-1 receptors or increased triglyceride levels in the liver.
The present study suggests that whereas GH plays a major role in inducing
insulin resistance, IGF-1 may have a direct modulatory role.&quot;,
&quot;author&quot; : [ { &quot;dropping-particle&quot; : &quot;&quot;,
&quot;family&quot; : &quot;Haluzik&quot;, &quot;given&quot; :
&quot;Martin&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot;
: false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Yakar&quot;, &quot;given&quot; :
&quot;Shoshana&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Gavrilova&quot;, &quot;given&quot; : &quot;Oksana&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;Setser&quot;, &quot;given&quot; :
&quot;Jennifer&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; }, {
&quot;dropping-particle&quot; : &quot;&quot;, &quot;family&quot; :
&quot;Boisclair&quot;, &quot;given&quot; : &quot;Yves&quot;,
&quot;non-dropping-particle&quot; : &quot;&quot;, &quot;parse-names&quot; :
false, &quot;suffix&quot; : &quot;&quot; }, { &quot;dropping-particle&quot; :
&quot;&quot;, &quot;family&quot; : &quot;LeRoith&quot;, &quot;given&quot; :
&quot;Derek&quot;, &quot;non-dropping-particle&quot; : &quot;&quot;,
&quot;parse-names&quot; : false, &quot;suffix&quot; : &quot;&quot; } ],
&quot;container-title&quot; : &quot;Diabetes&quot;, &quot;id&quot; :
&quot;ITEM-1&quot;, &quot;issue&quot; : &quot;10&quot;, &quot;issued&quot; : {
&quot;date-parts&quot; : [ [ &quot;2003&quot;, &quot;10&quot; ] ] },
&quot;page&quot; : &quot;2483-9&quot;, &quot;title&quot; : &quot;Insulin
resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by
deletion of the acid-labile subunit of the IGF-binding protein-3 complex:
relative roles of growth hormone and IGF-1 in insulin resistance.&quot;,
&quot;type&quot; : &quot;article-journal&quot;, &quot;volume&quot; :
&quot;52&quot; }, &quot;uris&quot; : [
&quot;http://www.mendeley.com/documents/?uuid=2cdc1f60-58c5-49e6-ad62-2be000110cef&quot;
] } ], &quot;mendeley&quot; : { &quot;previouslyFormattedCitation&quot; :
&quot;[10]&quot; }, &quot;properties&quot; : { &quot;noteIndex&quot; : 0 },
&quot;schema&quot; : &quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;
}<span style='mso-element:field-separator'></span></span></b><![endif]--><span
style='font-family:"Times New Roman";mso-fareast-font-family:"Times New Roman";
color:red;mso-no-proof:yes'>[10]</span><!--[if supportFields]><b
style='mso-bidi-font-weight:normal'><span style='font-family:"Times New Roman";
mso-fareast-font-family:"Times New Roman";color:red'><span style='mso-element:
field-end'></span></span></b><![endif]--><b style='mso-bidi-font-weight:normal'><span
style='font-family:"Times New Roman";mso-fareast-font-family:"Times New Roman";
color:red'>. Our data demonstrates that expression of the adipose tissue <i>IGF1</i>
gene correlates well with that of serum IGF-1. We can speculate that adipose
tissue may be a source of IGF-1 in <span class=SpellE>acromegalic</span>
subjects, potentially contributing to the remaining ~25% of IGF-1 that is not
altered by liver-specific <i style='mso-bidi-font-style:normal'>Igf1</i>
knockout.<span style="mso-spacerun:yes">&nbsp; </span>Further testing of this
hypothesis will require adipocyte-specific ablation of <i style='mso-bidi-font-style:
normal'>Igf1</i>.<o:p></o:p></span></b></p>

<ul type=disc>
 <li class=MsoNormal style='color:#333333;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;mso-list:l0 level1 lfo1;tab-stops:list .5in'><span style='font-family:
     "Times New Roman";mso-fareast-font-family:"Times New Roman"'>The authors
     consistently refer to the effects of excess GH due to acromegaly, while
     acromegaly also curses with elevated IGF-I levels and therefore both
     elevated GH and IGF-I levels contribute to the final observed phenotype.<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
margin-left:.5in'><b style='mso-bidi-font-weight:normal'><span
style='font-family:"Times New Roman";mso-fareast-font-family:"Times New Roman";
color:#333333'>As the reviewer suggests, we have pointed out in the
introduction that all <i style='mso-bidi-font-style:normal'>in vivo</i>
phenotypes associated with acromegaly may be due to either excessive GH or
IGF-1 levels due to their known interactions:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-left:1.0in;text-align:justify;text-justify:
inter-ideograph'><b style='mso-bidi-font-weight:normal'><span style='font-family:
"Times New Roman";color:red'>Growth hormone induces the expression and
secretion of IGF-1, so phenotypes associated with acromegaly may be due to
either GH signaling, IGF-1 signaling or a combination of both.<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
margin-left:.5in'><b style='mso-bidi-font-weight:normal'><span
style='font-family:"Times New Roman";mso-fareast-font-family:"Times New Roman";
color:#333333'>We have also mentioned this point in the revised discussion:<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
margin-left:1.0in'><b style='mso-bidi-font-weight:normal'><span
style='font-family:"Times New Roman";color:red'>Some of these genes may be
direct targets of increased GH or IGF-1 signaling in adipose tissue, whereas
others may be secondary adaptations to this condition.</span></b><b
style='mso-bidi-font-weight:normal'><span style='font-family:"Times New Roman";
mso-fareast-font-family:"Times New Roman";color:red'><o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
margin-left:.5in'><b style='mso-bidi-font-weight:normal'><span
style='font-family:"Times New Roman";mso-fareast-font-family:"Times New Roman";
color:#333333'>Furthermore have also extended our analyses to include an
evaluation of IGF-1 receptor levels in our dataset:<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
margin-left:1.0in'><b style='mso-bidi-font-weight:normal'><span
style='font-family:"Times New Roman";color:red'>Neither the growth hormone
receptor (GHR) nor the IGF-1 receptors (<i style='mso-bidi-font-style:normal'>IGF1R,</i>
<i style='mso-bidi-font-style:normal'>IGF2R)</i> was significantly altered in <span
class=SpellE>acromegalic</span> adipose tissue.<span
style="mso-spacerun:yes">&nbsp; </span></span></b><b style='mso-bidi-font-weight:
normal'><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman";color:red'><o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span
style='font-family:"Times New Roman";mso-fareast-font-family:"Times New Roman";
color:#333333'><o:p>&nbsp;</o:p></span></p>

<h1>References</h1>

<p style='margin-left:32.0pt;text-indent:-32.0pt'><!--[if supportFields]><span
style='font-family:"Times New Roman";mso-fareast-font-family:"Times New Roman";
color:#333333'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN
Mendeley Bibliography CSL_BIBLIOGRAPHY <span style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-no-proof:yes'>1. <span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Manetti
L, Bogazzi F, Giovannetti C, Raffaelli V, Genovesi M, et al. (2010) Changes in
coagulation indexes and occurrence of venous thromboembolism in patients with
Cushing’s syndrome: results from a prospective study before and after surgery.
Eur J Endocrinol 163: 783&#8211;791. doi:10.1530/EJE-10-0583.<o:p></o:p></span></p>

<p style='margin-left:32.0pt;text-indent:-32.0pt'><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-no-proof:yes'>2. <span
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Brummelman
P, Koerts J, Dullaart RPF, van den Berg G, Tucha O, et al. (2012) Effects of
previous growth hormone excess and current medical treatment for acromegaly on
cognition. Eur J Clin Invest 42: 1317&#8211;1324.
doi:10.1111/j.1365-2362.2012.02721.x.<o:p></o:p></span></p>

<p style='margin-left:32.0pt;text-indent:-32.0pt'><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-no-proof:yes'>3. <span
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Tiemensma
J, Biermasz NR, van der Mast RC, Wassenaar MJE, Middelkoop HAM, et al. (2010)
Increased psychopathology and maladaptive personality traits, but normal
cognitive functioning, in patients after long-term cure of acromegaly. J Clin
Endocrinol Metab 95: E392&#8211;402. doi:10.1210/jc.2010-1253.<o:p></o:p></span></p>

<p style='margin-left:32.0pt;text-indent:-32.0pt'><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-no-proof:yes'>4. <span
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Yedinak CG,
Fleseriu M (2014) Self-perception of cognitive function among patients with
active acromegaly, controlled acromegaly, and non-functional pituitary adenoma:
a pilot study. Endocrine 46: 585&#8211;593. doi:10.1007/s12020-013-0106-9.<o:p></o:p></span></p>

<p style='margin-left:32.0pt;text-indent:-32.0pt'><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-no-proof:yes'>5. <span
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Griffith M,
Griffith OL, Mwenifumbo J, Goya R, Morrissy a S, et al. (2010) Alternative
expression analysis by RNA sequencing. Nat Methods 7: 843&#8211;847.
doi:10.1038/nmeth.1503.<o:p></o:p></span></p>

<p style='margin-left:32.0pt;text-indent:-32.0pt'><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-no-proof:yes'>6. <span
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Asmann YW,
Klee EW, Thompson EA, Perez E a, Middha S, et al. (2009) 3’ tag digital gene
expression profiling of human brain and universal reference RNA using Illumina
Genome Analyzer. BMC Genomics 10: 531. doi:10.1186/1471-2164-10-531.<o:p></o:p></span></p>

<p style='margin-left:32.0pt;text-indent:-32.0pt'><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-no-proof:yes'>7. <span
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Wu AR, Neff
NF, Kalisky T, Dalerba P, Treutlein B, et al. (2014) Quantitative assessment of
single-cell RNA-sequencing methods. Nat Methods 11: 41&#8211;46.
doi:10.1038/nmeth.2694.<o:p></o:p></span></p>

<p style='margin-left:32.0pt;text-indent:-32.0pt'><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-no-proof:yes'>8. <span
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Shi Y, He M
(2014) Differential gene expression identified by RNA-Seq and qPCR in two sizes
of pearl oyster (Pinctada fucata). Gene 538: 313&#8211;322.
doi:10.1016/j.gene.2014.01.031.<o:p></o:p></span></p>

<p style='margin-left:32.0pt;text-indent:-32.0pt'><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-no-proof:yes'>9. <span
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Ayuk J,
Sheppard MC (2006) Growth hormone and its disorders. Postgrad Med J 82:
24&#8211;30. doi:10.1136/pgmj.2005.036087.<o:p></o:p></span></p>

<p style='margin-left:32.0pt;text-indent:-32.0pt'><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-no-proof:yes'>10. <span
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp; </span>Haluzik M, Yakar S,
Gavrilova O, Setser J, Boisclair Y, et al. (2003) Insulin resistance in the
liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the
acid-labile subunit of the IGF-binding protein-3 complex: relative roles of
growth hormone and IGF-1 in insulin resistance. Diabetes 52: 2483&#8211;2489. <o:p></o:p></span></p>

<p style='margin-left:32.0pt;text-indent:-32.0pt'><!--[if supportFields]><span
style='font-family:"Times New Roman";mso-fareast-font-family:"Times New Roman";
color:#333333'><span style='mso-element:field-end'></span></span><![endif]--><span
style='font-family:"Times New Roman";mso-fareast-font-family:"Times New Roman";
color:#333333'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span
style='font-family:"Times New Roman";mso-fareast-font-family:"Times New Roman";
color:#333333'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span style='font-family:"Times New Roman"'><o:p>&nbsp;</o:p></span></p>

</div>

<div style='mso-element:comment-list'><![if !supportAnnotations]>

<hr class=msocomoff align=left size=1 width="33%">

<![endif]></div>

</body>

</html>
